Highlights and Quick Summary
- EBT margin for the quarter ending June 30, 2023 was -537.29% (a -7.93% decrease compared to previous quarter)
- Year-over-year quarterly EBT margin increased by 2504.41%
- Annual EBT margin for 2022 was -183.23% (a -29.38% decrease from previous year)
- Annual EBT margin for 2021 was -259.46% (a 444.97% increase from previous year)
- Annual EBT margin for 2020 was -47.61% (a -44.14% decrease from previous year)
- Twelve month EBT margin ending June 30, 2023 was -185.87% (a -1.04% decrease compared to previous quarter)
- Twelve month trailing EBT margin increased by 35.67% year-over-year
Trailing EBT margin for the last four month:
| 30 Jun '23 | 31 Mar '23 | 31 Dec '22 | 30 Sep '22 |
|---|---|---|---|
| -185.87% | -187.82% | -183.23% | -137.0% |
Visit stockrow.com/DRRX
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical EBT margin of DURECT Corporation
Most recent EBT marginof DRRX including historical data for past 10 years.Interactive Chart of EBT margin of DURECT Corporation
DURECT Corporation EBT margin for the past 10 Years (both Annual and Quarterly)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2023 | -537.29% | -583.59% | – | – | – |
| 2022 | -315.81% | -20.63% | -556.41% | -566.16% | -183.23% |
| 2021 | -96.04% | -460.83% | -397.13% | -458.14% | -259.46% |
| 2020 | -399.32% | -513.26% | 56.84% | -636.55% | -47.61% |
| 2019 | -52.7% | -18.49% | -181.36% | -172.6% | -85.23% |
| 2018 | -2165.68% | -33.79% | -205.42% | -237.87% | -165.91% |
| 2017 | 42.15% | 29.46% | -229.84% | -177.67% | -7.51% |
| 2016 | -250.53% | -235.96% | -285.52% | -217.63% | -246.05% |
| 2015 | -113.12% | -136.77% | -123.35% | -101.68% | -118.51% |
| 2014 | -139.14% | -166.56% | -119.58% | -57.21% | -113.96% |
| 2013 | -118.91% | -203.1% | -131.32% | -124.8% | -139.97% |
| 2012 | -168.6% | -125.47% | – | – | 30.53% |
Business Profile of DURECT Corporation
Sector: Healthcare
Industry: Drug Manufacturers Specialty & Generic